secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inogen Inc (INGN)
CIK:        0001294133
Form:       8-K
Filed at:   2026-08-06T20:10:33+00:00
Accession:  0001294133-26-000032
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inogen Q2 revenue $95.1M (+3% YoY); raises FY adjusted EBITDA guidance to ~$4.0M
--------------------------------------------------------------------------------

- Q2 revenue $95.1M (+3% YoY); international revenue $41.3M (+14.8% YoY).
- GAAP net loss $3.9M vs $4.2M loss prior year; adjusted EBITDA positive $2.4M vs $2.1M.
- Raised FY 2026 adjusted EBITDA guidance to ~$4.0M (up 48% from 2025); revenue guidance $355M-$361M.
- Cash $106.8M, no debt; repurchased 1.15M shares for $7.5M in H1 2026.
- Launched Rove 6 in Canada; completed Simeox H study enrollment in China; added Andy Reding as COO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1294133/000129413326000032/0001294133-26-000032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1294133/000129413326000032/ingn-20260806.htm
  HTML page:      https://secwatch.observer/filing/0001294133-26-000032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer